No BS Just Facts logo
No BS Just Facts
It might be boring, but it's just the facts.

← All stories · business

CNBC

Novartis raises blockbuster drug forecasts to $18 billion as it seeks to prove growth can last

Thursday, November 19, 2026


Novartis raised peak sales forecasts for multiple drugs across multiple sclerosis, leukemia, and cholesterol treatments to $18 billion combined, citing strong demand. The company did not specify which drugs received upgraded forecasts or by how much each was increased. The announcement came as part of the company's effort to demonstrate sustained revenue growth.

Original reporting:

Next story

As some states move away from the death penalty, Florida prepares to set new record→